MLchartDataset catalogue

Ogsiveo

Term · Oncology and biomedicine · MLC-T-ONC-006032

A drug used to treat adults with desmoid tumors (a type of soft tissue tumor) that have gotten worse and need systemic therapy. It is also being studied in the treatment of other types of cancer. Ogsiveo binds to a protein called gamma secretase, which blocks the activation of other proteins called Notch receptors. Blocking these proteins may help keep tumor cells from growing and may kill them. Ogsiveo is a type of gamma secretase inhibitor. Also called nirogacestat hydrobromide.

Table 1. Record
IdentifierMLC-T-ONC-006032
FieldOncology and biomedicine
Synonymsnirogacestat hydrobromide
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006032",
  "term": "Ogsiveo",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with desmoid tumors (a type of soft tissue tumor) that have gotten worse and need systemic therapy. It is also being studied in the treatment of other types of cancer. Ogsiveo binds to a protein called gamma secretase, which blocks the activation of other proteins called Notch receptors. Blocking these proteins may help keep tumor cells from growing and may kill them. Ogsiveo is a type of gamma secretase inhibitor. Also called nirogacestat hydrobromide.",
  "synonyms": [
    "nirogacestat hydrobromide"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ogsiveo/"
}

Record 12,117 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.